Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Grace Ibitamuno"'
Autor:
Monica Sridhar, Leah Ramella, Abbey Eisenhower, Ana J. Schaefer, Marisa Petruccelli, Thomas I. Mackie, Grace Ibitamuno, Alice S. Carter, Shawna V. Hudson, R. Christopher Sheldrick
Publikováno v:
Journal of Clinical and Translational Science. 4:260-269
Introduction:Implementation scientists increasingly recognize that the process of implementation is dynamic, leading to ad hoc modifications that may challenge fidelity in protocol-driven interventions. However, limited attention to ad hoc modificati
Autor:
Denise V. Rodgers, Grace Ibitamuno
Publikováno v:
Junctures in Women's Leadership
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48c28805d4a8a1757f9b758b0a4de44b
https://doi.org/10.36019/9781978803725-010
https://doi.org/10.36019/9781978803725-010
Autor:
Grace Ibitamuno
Publikováno v:
Journal of cancer education : the official journal of the American Association for Cancer Education. 34(3)
Autor:
Andrea Bradfield, Jason S. McLellan, Jonathan M. Carlson, Paul T. Edlefsen, Philip Konopa, Mark S. deSouza, Vatcharain Assawadarachai, Julia N. Stoddard, Kim G. Wong, Jerome H. Kim, Snehal Nariya, Hong Zhao, Annemarie O'Sullivan, Meera Bose, Eric Sanders-Buell, William R. Schief, Morgane Rolland, Peter D. Kwong, Michal Juraska, Sergey Menis, Sodsai Tovanabutra, Allan C. deCamp, Wenjie Deng, James I. Mullins, Merlin L. Robb, Tomer Hertz, Brendan B. Larsen, Peter B. Gilbert, Grace Ibitamuno, Ivelin S. Georgiev, Adam Bates, Esther Lei, Robert J. O'Connell, Michelle Lazzaro, Lennie Chen, Hasan Ahmed, Craig A. Magaret, Brandon S. Maust, Shana Howell, Nelson L. Michael, Sorachai Nitayaphan, Chris Carrico, Supachai Rerks-Ngarm
Publikováno v:
Nature
Genetic analysis of breakthrough infections in people vaccinated against HIV-1 show that vaccine efficacy increased by up to 80% against viruses carrying two mutations in Env V2, but also raises the possibility of population-level adaptation to the v
Autor:
Adam Bates, Wenjie Deng, James I. Mullins, Merlin L. Robb, Tomer Hertz, Daniel E. Geraghty, Michelle Lazzaro, Kim G. Wong, Snehal Nariya, John McNevin, Grace Ibitamuno, Allan C. deCamp, Raphael Gottardo, Andrea Bradfield, Georgia D. Tomaras, Lennie Chen, Gustavo H. Kijak, Julia N. Stoddard, Annemarie O'Sullivan, Meera Bose, Sue Li, Jerome H. Kim, Philip Konopa, Eric Sanders-Buell, Daryl E. Morris, Supachai Rerks-Ngarm, Hasan Ahmed, Craig A. Magaret, Robert J. O'Connell, Sorachai Nitayaphan, David C. Montefiori, M. Juliana McElrath, Youyi Fong, Mark S. deSouza, Paul T. Edlefsen, Shana Howell, Vatcharain Assawadarachai, Sodsai Tovanabutra, Jodie P. Goodridge, Esther Lei, John Sidney, Nicole Frahm, Holly Janes, Peter B. Gilbert, Brendan B. Larsen, Alessandro Sette, Hong Zhao, Susan Zolla-Pazner, Andrew J. Gartland, Brandon S. Maust
The RV144 HIV-1 vaccine trial demonstrated partial efficacy of 31% against HIV-1 infection. Studies into possible correlates of protection found that antibodies specific to the V1 and V2 (V1/V2) region of envelope correlated inversely with infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::163146bf29c561514fdf01ca31183db2
https://europepmc.org/articles/PMC4135964/
https://europepmc.org/articles/PMC4135964/
Autor:
Tomer Hertz, Grace Ibitamuno, Allan C. deCamp, deSouza, Eric Sanders-Buell, Adam Bates, Meera Bose, Hasan Ahmed, MJ McElrath, Nelson L. Michael, Craig A. Magaret, S Nitayaphan, Peter B. Gilbert, Michelle Lazzaro, Daniel E. Geraghty, Shana Howell, Andrea Bradfield, Sodsai Tovanabutra, Jerome H. Kim, Gustavo H. Kijak, Wenjie Deng, James I. Mullins, Esther Lei, Paul T. Edlefsen, Youyi Fong, Kim G. Wong, Snehal Nariya, Brendan B. Larsen, Daryl E. Morris, Supachai Rerks-Ngarm, Vatcharain Assawadarachai, Andrew J. Gartland, Brandon S. Maust, Shuying Sue Li, Hong Zhao, Barton F. Haynes, Georgia D. Tomaras, Holly Janes, RJ O'Connel, Morgane Rolland, Merlin L. Robb
Publikováno v:
Retrovirology
Europe PubMed Central
Retrovirology, Vol 9, Iss Suppl 2, p O61 (2012)
Europe PubMed Central
Retrovirology, Vol 9, Iss Suppl 2, p O61 (2012)
T-cell based sieve analysis ties HLA A*02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial T Hertz, A Gartland, H Janes, S Li, Y Fong, GD Tomaras, D Morris, D Geraghty, GH Kijak, PT Edlefsen, M Rolland, BB Larsen, S Tovanabutra, E
Autor:
Merlin L. Robb, Dan H. Barouch, Jung-Hyun Kim, Matthieu Rolland, K Baldwin, Michelle Lazzaro, Adam Bates, Shana Howell, J Lee, T. Cervenka, Janelle Kuroiwa, Sodsai Tovanabutra, Annemarie O'Sullivan, S Sina, Meera Bose, Grace Ibitamuno, Nelson L. Michael, Robert J. O'Connell, Eric Sanders-Buell
Publikováno v:
Retrovirology, Vol 9, Iss Suppl 2, p O32 (2012)
Retrovirology
Retrovirology
Results The mean pairwise AA diversity among the 66 SIVMAC251 Env sequences was 0.38%, and they differed from the vaccine strain SIV SME543 (Env) by 21.94%. The repeated low-dose challenge resulted in infections with an average of 1.7 founder variant